Evidence map›Paper›PMID 20729402›Full record

ArticleAmerican journal of physiology. Heart and circulatory physiology2010

Upregulation of eNOS and unchanged energy metabolism in increased susceptibility of the aging type 2 diabetic GK rat heart to ischemic injury.

Martine Desrois, Kieran Clarke, Carole Lan, Christiane Dalmasso, Mark Cole, Bernard Portha, Patrick J Cozzone, Monique Bernard

Open access · greenAbstract read
In one paragraph

Article in American journal of physiology. Heart and circulatory physiology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 36 citations in OpenAlex.

  1. Vitamin DExperimental biology and medicine (Maywood, N.J.) · 2025
    Article
  2. Article
  3. CardiacHeart failure reviews · 2023
    Review
  4. Guidelines on models of diabetic heart disease.American journal of physiology. Heart and circulatory physiology · 2022
    Review
  5. Sex Differences of the Diabetic Heart.Frontiers in physiology · 2021
    Review
  6. Article
  7. Voltage dependence of the CaMolecular and cellular biochemistry · 2018
    Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Sex Differences in Metabolic Cardiomyopathy.Cardiovascular research · 2017
    Article
  13. Article
  14. Article
  15. Cardiac NO signalling in the metabolic syndrome.British journal of pharmacology · 2015
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 3 countries.

Martine DesroisCentre de Résonance Magnétique Biologique et Médicale, UMR CNRS n°6612, Faculté de Médecine de Marseille, Université de Méditerranée, 27 Bd Jean Moulin, 13385 Marseille Cedex 05, France. martine.desrois@univmed.fr
Kieran Clarke
Carole Lan
Christiane Dalmasso
Mark Cole
Bernard Portha
Patrick J Cozzone
Monique Bernard
Centre National pour la Recherche Scientifique et Technique (CNRST) · MACentre de Résonance Magnétique Biologique et Médicale · FRUniversity of Oxford · GBUniversité Paris Cité · FR

Funding

British Heart Foundation PS/02/002/14893British Heart Foundation RG/07/004/22659
6 · The paper itself

Abstract

We investigated the tolerance of the insulin-resistant diabetic heart to ischemic injury in the male Goto-Kakizaki (GK) rat, a model of type 2 diabetes. Changes in energy metabolism, nitric oxide (NO) pathway, and cardiac function were assessed in the presence of physiological substrates. Age-matched control Wistar (n = 19) and GK (n = 18) isolated rat hearts were perfused with 0.4 mM palmitate, 3% albumin, 11 mM glucose, 3 U/l insulin, 0.2 mM pyruvate, and 0.8 mM lactate for 24 min before switching to 1.2 mM palmitate (11 rats/group) during 32 min low-flow (0.5 ml·min(-1)·g wet wt(-1)) ischemia. Next, flow was restored with 0.4 mM palmitate buffer for 32 min. A subset of hearts from each group (n = 8 for control and n = 7 for GK groups) were freeze-clamped for determining baseline values after the initial perfusion of 24 min. ATP, phosphocreatine (PCr), and intracellular pH (pH(i)) were followed using (31)P magnetic resonance spectroscopy with simultaneous measurement of contractile function. The NO pathway was determined by nitric oxide synthase (NOS) isoform expression and total nitrate concentration (NOx) in hearts. We found that coronary flow was 26% lower (P < 0.05) during baseline conditions and 61% lower (P < 0.05) during reperfusion in GK vs. control rat hearts. Rate pressure product was lower during reperfusion in GK vs. control rat hearts (P < 0.05). ATP, PCr, and pH(i) during ischemia-reperfusion were similar in both groups. Endothelial NOS expression was increased in GK rat hearts during baseline conditions (P < 0.05). NOx was increased during baseline conditions (P < 0.05) and after reperfusion (P < 0.05) in GK rat hearts. We report increased susceptibility of type 2 diabetic GK rat heart to ischemic injury that is not associated with impaired energy metabolism. Reduced coronary flow, upregulation of eNOS expression, and increased total NOx levels confirm NO pathway modifications in this model, presumably related to increased oxidative stress. Modifications in the NO pathway may play a major role in ischemia-reperfusion injury of the type 2 diabetic GK rat heart.

Indexed as

AgingAnimalsCoronary VesselsDiabetes Mellitus, Type 2Disease Models, AnimalEnergy MetabolismHeartMaleMyocardial Reperfusion InjuryNitric OxideNitric Oxide Synthase Type IIIRatsRats, Mutant StrainsRats, WistarRegional Blood FlowUp-RegulationNitric OxideNitric Oxide Synthase Type III

Identifiers

PMID20729402
PMCPMC2993220
OpenAlexW1974143972

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.